IBD in 2011: Advances in IBD management--towards a tailored approach.
Inserm U995, Université Lille Nord de France, Lille F-59000, France.
Guillaume P
GP
Pineton de Chambrun
William J
WJ
Sandborn
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy* / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction / Q000379:methods*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha